ERK 1/2 activation does not contribute to increased survival mediated by bone marrow cells after 90% partial hepatectomy in Wistar rats

Detalhes bibliográficos
Autor(a) principal: Ochs de Muñoz, Gustavo Alfredo
Data de Publicação: 2017
Outros Autores: Kretzmann, Nelson Alexandre, López, Mónica Luján, Kieling, Carlos Oscar, Uribe-Cruz, Carolina, da Silva, Luciano Basso, Osvaldt, Alessandro Bersch, Matte, Ursula da Silveira
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinical and Biomedical Research
Texto Completo: https://seer.ufrgs.br/index.php/hcpa/article/view/68336
Resumo: We investigated the influence of bone marrow cells upon activation of ERK ½ in an animal model of 90% PH. Phosphorylated ERK 1/2 was evaluated by western blot. No differences were found between the groups. Thus, increased survival does not appear to be mediated by ERK 1/2 activation.Keywords: MAP Kinase Signaling System; stem cells; acute liver failure
id UFRGS-20_9d7913caa270993596eefe6c5dcc73e2
oai_identifier_str oai:seer.ufrgs.br:article/68336
network_acronym_str UFRGS-20
network_name_str Clinical and Biomedical Research
repository_id_str
spelling ERK 1/2 activation does not contribute to increased survival mediated by bone marrow cells after 90% partial hepatectomy in Wistar ratsMAP Kinase Signaling Systemstem cellsacute liver failureWe investigated the influence of bone marrow cells upon activation of ERK ½ in an animal model of 90% PH. Phosphorylated ERK 1/2 was evaluated by western blot. No differences were found between the groups. Thus, increased survival does not appear to be mediated by ERK 1/2 activation.Keywords: MAP Kinase Signaling System; stem cells; acute liver failureHCPA/FAMED/UFRGS2017-01-17info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer-reviewed Articleapplication/pdfhttps://seer.ufrgs.br/index.php/hcpa/article/view/68336Clinical & Biomedical Research; Vol. 36 No. 4 (2016): Clinical and Biomedical ResearchClinical and Biomedical Research; v. 36 n. 4 (2016): Clinical and Biomedical Research2357-9730reponame:Clinical and Biomedical Researchinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSenghttps://seer.ufrgs.br/index.php/hcpa/article/view/68336/pdfCopyright (c) 2017 Clinical and Biomedical Researchinfo:eu-repo/semantics/openAccessOchs de Muñoz, Gustavo AlfredoKretzmann, Nelson AlexandreLópez, Mónica LujánKieling, Carlos OscarUribe-Cruz, Carolinada Silva, Luciano BassoOsvaldt, Alessandro BerschMatte, Ursula da Silveira2024-01-19T14:25:16Zoai:seer.ufrgs.br:article/68336Revistahttps://www.seer.ufrgs.br/index.php/hcpaPUBhttps://seer.ufrgs.br/index.php/hcpa/oai||cbr@hcpa.edu.br2357-97302357-9730opendoar:2024-01-19T14:25:16Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.none.fl_str_mv ERK 1/2 activation does not contribute to increased survival mediated by bone marrow cells after 90% partial hepatectomy in Wistar rats
title ERK 1/2 activation does not contribute to increased survival mediated by bone marrow cells after 90% partial hepatectomy in Wistar rats
spellingShingle ERK 1/2 activation does not contribute to increased survival mediated by bone marrow cells after 90% partial hepatectomy in Wistar rats
Ochs de Muñoz, Gustavo Alfredo
MAP Kinase Signaling System
stem cells
acute liver failure
title_short ERK 1/2 activation does not contribute to increased survival mediated by bone marrow cells after 90% partial hepatectomy in Wistar rats
title_full ERK 1/2 activation does not contribute to increased survival mediated by bone marrow cells after 90% partial hepatectomy in Wistar rats
title_fullStr ERK 1/2 activation does not contribute to increased survival mediated by bone marrow cells after 90% partial hepatectomy in Wistar rats
title_full_unstemmed ERK 1/2 activation does not contribute to increased survival mediated by bone marrow cells after 90% partial hepatectomy in Wistar rats
title_sort ERK 1/2 activation does not contribute to increased survival mediated by bone marrow cells after 90% partial hepatectomy in Wistar rats
author Ochs de Muñoz, Gustavo Alfredo
author_facet Ochs de Muñoz, Gustavo Alfredo
Kretzmann, Nelson Alexandre
López, Mónica Luján
Kieling, Carlos Oscar
Uribe-Cruz, Carolina
da Silva, Luciano Basso
Osvaldt, Alessandro Bersch
Matte, Ursula da Silveira
author_role author
author2 Kretzmann, Nelson Alexandre
López, Mónica Luján
Kieling, Carlos Oscar
Uribe-Cruz, Carolina
da Silva, Luciano Basso
Osvaldt, Alessandro Bersch
Matte, Ursula da Silveira
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Ochs de Muñoz, Gustavo Alfredo
Kretzmann, Nelson Alexandre
López, Mónica Luján
Kieling, Carlos Oscar
Uribe-Cruz, Carolina
da Silva, Luciano Basso
Osvaldt, Alessandro Bersch
Matte, Ursula da Silveira
dc.subject.por.fl_str_mv MAP Kinase Signaling System
stem cells
acute liver failure
topic MAP Kinase Signaling System
stem cells
acute liver failure
description We investigated the influence of bone marrow cells upon activation of ERK ½ in an animal model of 90% PH. Phosphorylated ERK 1/2 was evaluated by western blot. No differences were found between the groups. Thus, increased survival does not appear to be mediated by ERK 1/2 activation.Keywords: MAP Kinase Signaling System; stem cells; acute liver failure
publishDate 2017
dc.date.none.fl_str_mv 2017-01-17
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Peer-reviewed Article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/68336
url https://seer.ufrgs.br/index.php/hcpa/article/view/68336
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/68336/pdf
dc.rights.driver.fl_str_mv Copyright (c) 2017 Clinical and Biomedical Research
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2017 Clinical and Biomedical Research
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv HCPA/FAMED/UFRGS
publisher.none.fl_str_mv HCPA/FAMED/UFRGS
dc.source.none.fl_str_mv Clinical & Biomedical Research; Vol. 36 No. 4 (2016): Clinical and Biomedical Research
Clinical and Biomedical Research; v. 36 n. 4 (2016): Clinical and Biomedical Research
2357-9730
reponame:Clinical and Biomedical Research
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Clinical and Biomedical Research
collection Clinical and Biomedical Research
repository.name.fl_str_mv Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv ||cbr@hcpa.edu.br
_version_ 1799767054121697280

Registros relacionados